An investigation of cell proliferation and soluble mediators induced by interleukin 1β in human synovial fibroblasts: Comparative response in osteoarthritis and rheumatoid arthritis

Inflammation Research

Volumn 50, Issue 2, 2001, Pages 65-72

  Inoue, H ^a   Takamori, M ^a   Nagata, N ^a   Nishikawa, T ^b   Oda, H ^b   Yamamoto, S ^c   Koshihara, Y ^d  

^a Minophagen Pharmaceutical Co   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Tokyo Metropolitan Institute of Gerontology   (Japan)

^d TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

Cytokines; Osteoarthritis; Proliferation; Rheumatoid arthritis; Synovial fibroblasts

Indexed keywords

COLONY STIMULATING FACTOR 1; DEXAMETHASONE; INTERLEUKIN 1BETA; METHOTREXATE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E2; VASCULOTROPIN;

ARTICLE; CARTILAGE DEGENERATION; CELL PROLIFERATION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; MEDIATOR RELEASE; OSTEOARTHRITIS; PROTEIN PHOSPHORYLATION; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SKIN FIBROBLAST; STRAIN DIFFERENCE; SYNOVIAL FLUID; SYNOVIUM;

ARTHRITIS, RHEUMATOID; CELL DIVISION; DEXAMETHASONE; DINOPROSTONE; ENDOTHELIAL GROWTH FACTORS; FIBROBLASTS; GLUCOCORTICOIDS; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; INTERLEUKIN-8; KINETICS; LYMPHOKINES; MACROPHAGE COLONY-STIMULATING FACTOR; MATRIX METALLOPROTEINASE 1; OSTEOARTHRITIS; SOLUBILITY; SYNOVIAL MEMBRANE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035094703     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050726     Document Type: Article

References (37)

1. Rheumatoid arthritis: Pathophysiology and implications for therapy
2. Ethiopathogenesis of osteoarthritis
3. Role of cytokines in rheumatoid arthritis
4. Matrix metalloproteinases: A review
5. Prostaglandins in the rheumatic diseases
6. Stimulation of human synovial fibroblast DNA synthesis by recombinant human cytokines
7. 2 production by human synovial cells
8. Synovium as a source of interleukin 6 in vitro: Contribution to local and systemic manifestations of arthritis
9. Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1β
10. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
11. Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis
12. Invasive fibroblast-like synoviocytes in rheumatoid arthritis
13. Role of cytokines in inflammatory synovitis: The coordinate regulation of intracellular adhesion molecule 1 and HLA class I and class II antigens in rheumatoid synovial fibroblasts
14. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritis
15. Cytokine inter-relationships and their association with disease activity in arthritis
16. A new mechanism of bone destruction in rheumatoid arthritis: Synovial fibroblasts induce osteoclastogenesis
17. A new sulfonated tetrazolium salt that produces a highly water-soluble formazan dye
18. New insights into the mode of action of anti-inflammatory drugs
19. NS-398, an new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro
20. The natural product hymenialdisine inhibits interleukin-8 production in U 937 cells by inhibition of neuclear factor-κB
21. 2 formation by the marine natural product hymenialdisine
22. Characteristics of human synovial fibroblast activation by IL-1β and TNFα
23. A rapid and convenient assay for counting cells cultured in microwell plates: Application for assessment of growth factors
24. Effects of human recombinant IL-1β on rheumatoid and non rheumatoid human synovial cell growth
25. Comparative proliferation of non-rheumatoid and rheumatoid human synovial cells
26. Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts
27. NF-κB activation provides the potential link between inflammation and hyperplasia in the arthritic joint
28. Antisense oligonucleotides targeting c-fos mRNA inhibit rheumatoid synovial fibroblast proliferation
29. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids
30. Immunosuppression by glucocorticoids: Inhibition of NF-κB activity through induction of IκB synthesis
31. Transcriptional interference between c-Jun and the glucocorocoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction
32. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1β, phorbolester, and corticosteroids
33. 2
34. Signal transduction and transcription factors in rheumatic disease
35. Jun N-terminal kinase in rheumatoid arthritis
36. Effects of antirheumatic agents on cytokines
37. NF-κB regulation by IκB kinase in primary fibroblasts-like synoviocytes